Shandong University of Traditional Chinese Medicine, Jinan.
Tai'an Hospital of Traditional Chinese Medicine, Tai'an.
Medicine (Baltimore). 2021 Feb 19;100(7):e24810. doi: 10.1097/MD.0000000000024810.
Infertility is a kind of global disease. Fallopian tubal obstruction is one of the most important causes of female infertility. Complementary and alternative therapies are effective in treating tubal obstructive infertility, but there is no study on a comprehensive comparison among them. So, the purpose of this paper is to evaluate the efficacy and safety of different complementary and alternative therapies for tubal obstructive infertility.
We will search for randomized controlled trials (RCTs) from the following databases: PubMed, Cochrane Library, EMBASE, Web of Science, Chinese Biomedical Literature Database (SinoMed), Chinese National Knowledge Infrastructure (CNKI), Wanfang database, and VIP database. We will assess the risk of bias of the included studies with the Cochrane tool, and the strength of evidence with the GRADE approach. Both pairwise meta-analyses and network meta-analyses will be performed to examine the relative efficacy and safety of complementary and alternative therapies in the treatment of tubal obstructive infertility.
Our findings will provide clear evidence based on current available studies, which may lead to some proposals for both patients and researchers.
INPLASY202110076.
不孕症是一种全球性疾病。输卵管阻塞是女性不孕的最重要原因之一。补充和替代疗法在治疗输卵管阻塞性不孕方面有效,但尚无综合比较它们的研究。因此,本文旨在评估不同补充和替代疗法治疗输卵管阻塞性不孕的疗效和安全性。
我们将从以下数据库中检索随机对照试验(RCT):PubMed、Cochrane 图书馆、EMBASE、Web of Science、中国生物医学文献数据库(SinoMed)、中国知网(CNKI)、万方数据库和 VIP 数据库。我们将使用 Cochrane 工具评估纳入研究的偏倚风险,并使用 GRADE 方法评估证据强度。我们将进行两两荟萃分析和网络荟萃分析,以检验补充和替代疗法治疗输卵管阻塞性不孕的相对疗效和安全性。
我们的研究结果将基于现有研究提供明确的证据,这可能为患者和研究人员提供一些建议。
INPLASY 注册号:INPLASY202110076。